Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;47(1):33-50.
doi: 10.1016/j.ecl.2017.10.001.

Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction

Ben Brannick  1 , Sam Dagogo-Jack  2
Affiliations
Review

Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction

Ben Brannick et al. Endocrinol Metab Clin North Am. 2018 Mar.

Abstract

Prediabetes is a state characterized by impaired fasting glucose or impaired glucose tolerance. This review discusses the pathophysiology and macrovascular complications of prediabetes. The pathophysiologic defects underlying prediabetes include insulin resistance, alpha- and beta-cell dysfunction, increased lipolysis, inflammation, and suboptimal incretin effect. Recent studies have revealed that the long-term complications of diabetes manifest in some people with prediabetes; these complications include microvascular and macrovascular disorders. Finally, we present an overview of randomized control trials aimed at preventing progression from prediabetes to type 2 diabetes and discuss their implications for macrovascular risk reduction.

Keywords: Cardiovascular disease; Impaired fasting glucose; Impaired glucose tolerance; Macrovascular; Prediabetes complications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Recognized pathophysiological defects in type 2 diabetes mellitus and prediabetes. From Dagogo-Jack, S. Diabetes risks from prescription and nonprescription drugs. ADA press, Alexandria VA, 2016, with permission.
Figure 2
Figure 2
Recognized macrovascular complications associated with prediabetes. Data from references–.
See this image and copyright information in PMC

References

    1. World Health Organization. World Health Organization. Geneva (Switzerland): 2016. Global status report on noncommunicable diseases 2016.
    1. Dall TM, Yang W, Halder P, et al. The Economic Burden of Elevated Blood Glucose Levels in 2012. Diabetes Care. 2014;37:3172–3179. - PubMed
    1. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:293–301. - PubMed
    1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013 Apr;36(4):1033–46. - PMC - PubMed
    1. DeFronzo RA, Abdul-Ghani M. Assessment treatment of cardiovascular risk in prediabetes: impaired glucose tolerance impaired fasting glucose. Am J Cardiol. 2011;108:3B–24B. - PubMed

Publication types

MeSH terms